Bookmark

Add to MyYahoo RSS

Bloomsbury Publishing News

News on Bloomsbury Publishing (Ticker: BMY) continually updated from thousands of sources around the net.

11 hrs ago | Customer Interaction Solutions

U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein...

U.S. FDA Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism , and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy Bristol-Myers Squibb Company and Pfizer Inc. today announced the U.S. Food and Drug Administration has approved a Supplemental New Drug Application for Eliquis for the ... (more)

Comment?

Related Topix: Healthcare Law, Food and Drug Administration, Law, Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Publishing, Media, Medarex, Pfizer

15 hrs ago | AmericanBankingNews.com

Bristol-Myers Squibb SVP Sells $997,800 in Stock

Bristol-Myers Squibb SVP Autenried Paul Von unloaded 20,000 shares of Bristol-Myers Squibb stock in a transaction that occurred on Tuesday, August 19th.

Comment?

Related Topix: Bristol Myers Squibb, Biotech, Medicine, Healthcare Industry, Media, Publishing, Medarex

Wed Aug 20, 2014

Biopharm

Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen

Bristol-Myers Squibb and Celgene have established a clinical-trial collaboration to evaluate the safety, tolerability, and preliminary efficacy of a combination regimen of Bristol-Myers Squibb's investigational PD-1 immune checkpoint inhibitor, OPDIVO , and Celgene's nab technology-based chemotherapy ABRAXANE , in a Phase I study.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Cancer, Health

Tue Aug 19, 2014

Business Journal

Amgen enters heavyweight fray for Kendall Square's few remaining blocks of space

Amgen is on the hunt for 150,000 square feet of space in Cambridge, although a spokewoman said the long-term plan is to build out the company's existing footprint at 360 Binney St. .

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Boston, MA, Bristol Myers Squibb, Publishing, Media, Medarex

Business Journal

Bristol-Myers Squibb targets major block of space in East Cambridge

Bristol-Myers Squibb is vetting several property options in East Cambridge, increasingly the office and lab market of choice for many of the largest life sciences companies in the world.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals, Waltham, MA

Mon Aug 18, 2014

Business Journal

Bristol-Myers Squibb targets major block of space in East Cambridge

Bristol-Myers Squibb is vetting several property options in East Cambridge, increasingly the office and lab market of choice for many of the largest life sciences companies in the world.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals, Waltham, MA

BayStreet.ca

Premier Biotechnology & Anti-CTLA4

Whitefish, MT / August 18, 2014 / Many forms of cancer are characterized by a lack of cellular apoptosis and down-regulation of the immune system.

Comment?

Related Topix: Whitefish, MT, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Healthcare Industry, Food and Drug Administration

Mon Aug 11, 2014

Benzinga

Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments

U.S. markets managed to squeeze out small gains in lighter than normal volume as geopolitical tensions may be calming down.

Comment?

Related Topix: Investment Banking, Jefferies Group, Investment Services, Financial Services, Bristol Myers Squibb, Biotech, Media, Publishing, Medarex, Medicine, Healthcare Industry, Banking, Citigroup, CitiMortgage

AmericanBankingNews.com

Bristol-Myers Squibb Price Target Raised to $45.00 at Jefferies Group

The firm currently has a "hold" rating on the stock. Jefferies Group's price target suggests a potential downside of 8.52% from the company's current price.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Publishing, Media, Medarex, Investment Banking, Financial Services, Jefferies Group, Investment Services

Thu Aug 07, 2014

JD Supra

Court Report -- Part II: August 2014

Medicines Company v. Accord Healthcare, Inc. et al. 1:14-cv-00626; filed July 24, 2014 in the Middle District of North Carolina Infringement of U.S. Patent Nos.

Comment?

Related Topix: 9, Biotech, Medicines Company The, Medicine, Healthcare Industry, Bristol Myers Squibb, Publishing, Media, Bristol-Myers Squibb, Pharmaceuticals

Sys-Con Media

Leica Biosystems and Bristol-Myers Squibb Enter Into a Development...

Leica Biosystems will develop fully automated tissue-based companion diagnostic tests to run on the BONDa automated advanced staining systems Leica Biosystems, today announced an agreement with Bristol-Myers Squibb Company to collaborate on developing companion diagnostics on the Leica BOND system for use as an aid in selecting patients for ... (more)

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals

Tue Aug 05, 2014

BioSpace

Alder Biopharmaceuticals Inc. Reports Second Quarter 2014 Financial And Operating Results

Alder BioPharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, autoimmune and inflammatory diseases, today provided recent corporate highlights and reported its financial results for the second quarter ended June 30, 2014.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Psoriatic Arthritis, Health

Business Journal

Allied Minds and Bristol Myers to start 10 new biotechs in next five years

A new partnership being touted by Boston-based Allied Minds will create about 10 biotechs over the next five years - including several in the Bay State - that could then be acquired by New York drug giant Bristol-Myers Squibb .

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals

Mon Aug 04, 2014

Customer Interaction Solutions

Allied Minds and Bristol-Myers Squibb Form New Enterprise to Advance...

Allied Minds and Bristol-Myers Squibb Company today announced the formation of Allied-Bristol Life Sciences LLC, a new jointly owned enterprise created to identify and foster research and pre-clinical development of biopharmaceutical innovations from leading university research institutions across the U.S. Allied-Bristol Life Sciences LLC will ... (more)

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Publishing, Media, Medarex, Bristol-Myers Squibb

Fri Aug 01, 2014

Barron's

Bristol-Myers to Be Crowned With Royalties

With investors heavily focused on the immuno-oncology space, we are surprised by the lack of attention on recent intellectual-property developments in this highly attractive commercial market.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Publishing, Media

Thu Jul 31, 2014

West Australian

AstraZeneca raises earnings outlook as sales climb

British-Swedish drugmaker AstraZeneca, which fought off a takeover from Pfizer earlier this year, raised its 2014 earnings outlook on Thursday and posted rising second-quarter sales.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry

Wed Jul 30, 2014

GuruFocus.com

Vanguard Health Care Fund's Top Second Quarter Stocks

Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.

Comment?

Related Topix: Financial Markets, Biotech, Merck , Medicine, Healthcare Industry, Bristol Myers Squibb, Publishing, Media, Bristol-Myers Squibb, Pharmaceuticals

The Daily Caller

Selena Gomez Shows Off Skin In Snakeskin Halter Top

The movie, which has the same producer as the 1999 classic "Ten Things I Hate About You," premieres Aug. 1. Meanwhile, Justin Bieber was getting swung on by Orlando Bloom .

Comment?

Related Topix: Charitable Organizations, American Cancer Society, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry

Tue Jul 29, 2014

Pharmaceutical Processing

European Commission Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Bristol-Myers Squibb and Pfizer announced that the European Commission has approved Eliquis for the treatment of DVT and PE, and the prevention of recurrent DVT and PE in adults.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Pfizer

Mon Jul 28, 2014

Pharmaceutical Technology

Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies

Bristol-Myers Squibb and Ono Pharmaceutical signed a collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea, and Taiwan.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Health, Lung Cancer

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••